EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Bank of Cyprus (BOCH CY) Cyprus

Financials

ResearchGreece

ResearchGreece was not surprised the bank raised its FY24 RoTE guidance to >24% from >17% following Q2 results (they had been expecting this ever since Q1). Meanwhile, management has announced its decision to list the stock on the ATHEX (and de-list from the LSE) which should improve trading liquidity. ResearchGreece reiterates their OWN IT (OI) rating and raises their TP to €5.8. This comes as the result of their higher estimates in 2024-2026. They expect dividends of €180m-€195m in 2024-2025 on 40% and 50% payout respectively, pointing to a dividend yield of >10% at current prices.

Edition: 193

- 23 August, 2024


Bank of Cyprus (BOCH CY) Cyprus

Financials

ResearchGreece

The bank has reported a super strong set of Q2 results, driven by the wide(r) loan-deposit rate asymmetry boosting NII +21% Q/Q / +164% Y/Y, with clean RoTE at 25% (vs. 21% in Q1). ResearchGreece raises their 2023 RoTE estimate to 19.6% (vs. management guidance of >17%) and reiterates their OWN IT (OI) rating with a TP of €5.9 (100% upside). Unless earnings are hit by a windfall tax, they expect the 30% minimum pay-out guidance to equal a 9% dividend yield next year and rise closer to 10% by 2025; shareholders will be pocketing c.30% of the bank’s M/Cap in the form of dividends during 2023-25.

Edition: 167

- 18 August, 2023


Greek Equities: Impressive gains YTD

ResearchGreece

ResearchGreece’s base case scenario is materialising - Mitsotakis administration renewing its mandate and Greece avoiding a recession. With Greek equities +c.35% YTD they provide an update on the investment case for all the stocks under their coverage including:

Jumbo (BELA GA) - Working for the right reasons, namely valuation, balance sheet, management, business model, growth and dividends. The biggest risk: EU-China geopolitical issues affecting the firm's 70% merchandise sourcing.
Mytilineos (MYTIL GA) - Rating seems wrong, but concerns seem right, namely cash flow generation, corporate governance, energy crisis gains, cyclicality and low visibility. TP €17 (50% downside).
Bank of Cyprus (BOCH CY) - The best bank in Greece / Cyprus, worth >1.0x TBV based on RoTE >17% in 2023 (and >13% in 2025) and CoE of 12%. The first bank in the region to resume dividend payments (>8% next year). TP €5.7 (90% upside).

Edition: 164

- 07 July, 2023


Bank of Cyprus (BOCH CY) Cyprus

Financials

ResearchGreece

Not for turning - Board rejects Lone Star’s latest €1.51 per share offer. What should shareholders do? If you believe BoC’s RoTE will not exceed 5% by 2024 you are better off selling at any price close to €1.50. However, ResearchGreece’s base case scenario is that BoC’s RoTE will reach 7.5% in 2024 and rise to 8.3% in 2025 (both of which are below management guidance) and calculates the equity is worth €2.08-€2.19 per share (60%-70% upside). Sees no reason for the bank to trade below the average 0.43x P/TBV 2023E of its Greek peers or even below the 0.50x-0.54x of best NPE/CET1 positioned Eurobank and National Bank of Greece.

Edition: 143

- 02 September, 2022